Back to search

Article

Elevated circulating levels of phenylacetylglutamine in stroke patients with T2D are linked to specific gut microbiota

2022-06-22

Abstract excerpt

<title>Abstract</title> <p>Objective Type 2 diabetes (T2D) aggravates the injury of ischemic stroke (IS). The alterations of gut microbiota and its metabolite phenylacetylglutamine (PAGln) levels in stroke patients with T2D remain unclear. Therefore, our study aimed to explore the differences in gut microbiota and its metabolite PAGln between IS patients with and without T2D. Methods In our study, 35 IS with T2...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
666cad77-69f2-5656-a886-04cb665e6660
DOI
10.21203/rs.3.rs-1245321/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Elevated circulating levels of phenylacetylglutamine in stroke patients with T2D are linked to specific gut microbiotaDOI 10.21203/rs.3.rs-1245321/v2
Select a neighboring publication to make it the new centre.